Top ▲
Gene and Protein Information | ||||||
class A G protein-coupled receptor | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 7 | 391 | 14q13 | SSTR1 | somatostatin receptor 1 | 55-56 |
Mouse | 7 | 391 | 12 25.61 cM | Sstr1 | somatostatin receptor 1 | 55 |
Rat | 7 | 391 | 6q23 | Sstr1 | somatostatin receptor 1 | 28 |
Previous and Unofficial Names |
SRIF-2 | SS1R |
Database Links | |
Specialist databases | |
GPCRdb | ssr1_human (Hs), ssr1_mouse (Mm), ssr1_rat (Rn) |
Other databases | |
Alphafold | P30872 (Hs), P30873 (Mm), P28646 (Rn) |
ChEMBL Target | CHEMBL1917 (Hs), CHEMBL4242 (Mm), CHEMBL4652 (Rn) |
DrugBank Target | P30872 (Hs) |
Ensembl Gene | ENSG00000139874 (Hs), ENSMUSG00000035431 (Mm), ENSRNOG00000048145 (Rn) |
Entrez Gene | 6751 (Hs), 20605 (Mm), 25033 (Rn) |
Human Protein Atlas | ENSG00000139874 (Hs) |
KEGG Gene | hsa:6751 (Hs), mmu:20605 (Mm), rno:25033 (Rn) |
OMIM | 182451 (Hs) |
Pharos | P30872 (Hs) |
RefSeq Nucleotide | NM_001049 (Hs), NM_009216 (Mm), NM_012719 (Rn) |
RefSeq Protein | NP_001040 (Hs), NP_033242 (Mm), NP_036851 (Rn) |
UniProtKB | P30872 (Hs), P30873 (Mm), P28646 (Rn) |
Wikipedia | SSTR1 (Hs) |
Natural/Endogenous Ligands |
cortistatin-14 {Sp: Mouse, Rat} |
CST-17 {Sp: Human} |
SRIF-14 {Sp: Human, Mouse, Rat} |
SRIF-28 {Sp: Human, Mouse, Rat} |
Comments: SRIF-14 and SRIF-28 are the active fragments of precursor somatostatin |
Download all structure-activity data for this target as a CSV file
Agonists | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific agonist tables |
Antagonists | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
||
|
||
|
||
|
Primary Transduction Mechanisms | |
Transducer | Effector/Response |
Gi/Go family | Adenylyl cyclase inhibition |
References: 20,23,46 |
Secondary Transduction Mechanisms | |
Transducer | Effector/Response |
G protein (identity unknown) | Other - See Comments |
Comments: PTX-insensitive G-proteins activate protein tyrosine phosphatases (PTPs) and the Na+/H+ exchanger (NHE1). | |
References: 8,20,30 |
Tissue Distribution | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Expression Datasets | |
|
Functional Assays | ||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
Physiological Functions | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
Physiological Consequences of Altering Gene Expression | ||||||||||
|
||||||||||
|
||||||||||
|
Phenotypes, Alleles and Disease Models | Mouse data from MGI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1. Adams RL, Adams IP, Lindow SW, Atkin SL. (2004) Inhibition of endothelial proliferation by the somatostatin analogue SOM230. Clin Endocrinol (Oxf), 61 (4): 431-6. [PMID:15473874]
2. Akbar M, Okajima F, Tomura H, Majid MA, Yamada Y, Seino S, Kondo Y. (1994) Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett, 348 (2): 192-6. [PMID:8034040]
3. Arena S, Pattarozzi A, Corsaro A, Schettini G, Florio T. (2005) Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways. Mol Endocrinol, 19 (1): 255-67. [PMID:15388796]
4. Beaudet A, Greenspun D, Raelson J, Tannenbaum GS. (1995) Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function. Neuroscience, 65 (2): 551-61. [PMID:7777168]
5. Bigiani A, Petrucci C, Ghiaroni V, Dal Monte M, Cozzi A, Kreienkamp HJ, Richter D, Bagnoli P. (2004) Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res, 1025 (1-2): 177-85. [PMID:15464758]
6. Breder CD, Yamada Y, Yasuda K, Seino S, Saper CB, Bell GI. (1992) Differential expression of somatostatin receptor subtypes in brain. J Neurosci, 12 (10): 3920-34. [PMID:1403090]
7. Bruns C, Raulf F, Hoyer D, Schloos J, Lübbert H, Weckbecker G. (1996) Binding properties of somatostatin receptor subtypes. Metab Clin Exp, 45 (8 Suppl 1): 17-20. [PMID:8769372]
8. Buscail L, Delesque N, Estève JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV et al.. (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA, 91 (6): 2315-9. [PMID:7907795]
9. Bär KJ, Schurigt U, Scholze A, Segond Von Banchet G, Stopfel N, Bräuer R, Halbhuber KJ, Schaible HG. (2004) The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats. Neuroscience, 127 (1): 197-206. [PMID:15219682]
10. Casini G, Dal Monte M, Petrucci C, Gambellini G, Grouselle D, Allen JP, Kreienkamp HJ, Richter D, Epelbaum J, Bagnoli P. (2004) Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2. Eur J Neurosci, 19 (1): 43-54. [PMID:14750962]
11. Cervia D, Zizzari P, Pavan B, Schuepbach E, Langenegger D, Hoyer D, Biondi C, Epelbaum J, Bagnoli P. (2003) Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology, 44 (5): 672-85. [PMID:12668053]
12. Chen L, Tashjian Jr AH. (1999) Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry. Cell Signal, 11 (7): 499-505. [PMID:10405760]
13. Dal Monte M, Petrucci C, Vasilaki A, Cervia D, Grouselle D, Epelbaum J, Kreienkamp HJ, Richter D, Hoyer D, Bagnoli P. (2003) Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology, 45 (8): 1080-92. [PMID:14614951]
14. Engström M, Tomperi J, El-Darwish K, Ahman M, Savola JM, Wurster S. (2005) Superagonism at the human somatostatin receptor subtype 4. J Pharmacol Exp Ther, 312 (1): 332-8. [PMID:15333679]
15. Erchegyi J, Hoeger CA, Low W, Hoyer D, Waser B, Eltschinger V, Schaer JC, Cescato R, Reubi JC, Rivier JE. (2005) Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan. J Med Chem, 48: 507-514. [PMID:15658864]
16. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ. (1994) The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol, 8 (10): 1289-97. [PMID:7854346]
17. Florio T, Yao H, Carey KD, Dillon TJ, Stork PJ. (1999) Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol Endocrinol, 13 (1): 24-37. [PMID:9892010]
18. Helboe L, Stidsen CE, Moller M. (1998) Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus. J Neurosci, 18 (13): 4938-45. [PMID:9634559]
19. Hervieu G, Emson PC. (1998) The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience, 85 (4): 1263-84. [PMID:9681962]
20. Hou C, Gilbert RL, Barber DL. (1994) Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2. J Biol Chem, 269 (14): 10357-62. [PMID:8144617]
21. Hoyer D, Nunn C, Hannon J, Schoeffter P, Feuerbach D, Schuepbach E, Langenegger D, Bouhelal R, Hurth K, Neumann P et al.. (2004) SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist. Neurosci Lett, 361 (1-3): 132-5. [PMID:15135911]
22. Imhof AK, Glück L, Gajda M, Lupp A, Bräuer R, Schaible HG, Schulz S. (2011) Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis Rheum, 63 (8): 2352-62. [PMID:21506098]
23. Kaupmann K, Bruns C, Hoyer D, Seuwen K, Lubbert H. (1993) Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett, 331: 53-59. [PMID:8405411]
24. Kreienkamp HJ, Akgün E, Baumeister H, Meyerhof W, Richter D. (1999) Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett, 462 (3): 464-6. [PMID:10622746]
25. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC. (1999) Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes, 48 (1): 77-85. [PMID:9892225]
26. Lambertini C, Barzaghi-Rinaudo P, D'Amato L, Schulz S, Nuciforo P, Schmid HA. (2013) Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies. Regul Pept, 187: 35-41. [PMID:24188818]
27. Lanneau C, Viollet C, Faivre-Bauman A, Loudes C, Kordon C, Epelbaum J, Gardette R. (1998) Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT-PCR study. Eur J Neurosci, 10 (1): 204-12. [PMID:9753128]
28. Li XJ, Forte M, North RA, Ross CA, Snyder SH. (1992) Cloning and expression of a rat somatostatin receptor enriched in brain. J Biol Chem, 267 (30): 21307-12. [PMID:1400442]
29. Liapakis G, Tallent M, Reisine T. (1996) Molecular and functional properties of somatostain receptor subtypes. Metab Clin Exp, 45 (8 Suppl 1): 12-3. [PMID:8769370]
30. Lin CY, Varma MG, Joubel A, Madabushi S, Lichtarge O, Barber DL. (2003) Conserved motifs in somatostatin, D2-dopamine, and alpha 2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1. J Biol Chem, 278 (17): 15128-35. [PMID:12566440]
31. Lupp A, Nagel F, Schulz S. (2013) Reevaluation of sst₁ somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7. Regul Pept, 183: 1-6. [PMID:23466804]
32. Mastrodimou N, Thermos K. (2004) The somatostatin receptor (sst1) modulates the release of somatostatin in rat retina. Neurosci Lett, 356 (1): 13-6. [PMID:14746890]
33. Meyerhof W. (1998) The elucidation of somatostatin receptor functions: a current view. Rev Physiol Biochem Pharmacol, 133: 55-108. [PMID:9600011]
34. Nunn C, Schoeffter P, Langenegger D, Hoyer D. (2003) Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806. Naunyn Schmiedebergs Arch Pharmacol, 367 (1): 1-9. [PMID:12616335]
35. Patel YC, Srikant CB. (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology, 135 (6): 2814-7. [PMID:7988476]
36. Poitout L, Roubert P, Contour-Galcéra MO, Moinet C, Lannoy J, Pommier J, Plas P, Bigg D, Thurieau C. (2001) Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity. J Med Chem, 44 (18): 2990-3000. [PMID:11520208]
37. Portela-Gomes GM, Stridsberg M, Grimelius L, Oberg K, Janson ET. (2000) Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol, 8 (2): 126-32. [PMID:10937060]
38. Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell GI, Reisine T. (1993) Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol, 43 (6): 838-44. [PMID:8100350]
39. Reubi JC, Eisenwiener KP, Rink H, Waser B, Mäcke HR. (2002) A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur J Pharmacol, 456 (1-3): 45-9. [PMID:12450568]
40. Rivier JE, Hoeger C, Erchegyi J, Gulyas J, DeBoard R, Craig AG, Koerber SC, Wenger S, Waser B, Schaer JC et al.. (2001) Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). J Med Chem, 44 (13): 2238-46. [PMID:11405660]
41. Rivier JE, Kirby DA, Erchegyi J, Waser B, Eltschinger V, Cescato R, Reubi JC. (2005) Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides. J Med Chem, 48: 515-522. [PMID:15658865]
42. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F et al.. (1998) Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science, 282 (5389): 737-40. [PMID:9784130]
43. Schindler M, Harrington KA, Humphrey PP, Emson PC. (1995) Cellular localisation and co-expression of somatostatin receptor messenger RNAs in the human brain. Brain Res Mol Brain Res, 34 (2): 321-6. [PMID:8750836]
44. Schmid HA, Schoeffter P. (2004) Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors. Neuroendocrinology, 80 Suppl 1: 47-50. [PMID:15477717]
45. Schulz S, Händel M, Schreff M, Schmidt H, Höllt V. (2000) Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Physiol Paris, 94 (3-4): 259-64. [PMID:11088003]
46. Siehler S, Hoyer D. (1999) Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity. Naunyn Schmiedebergs Arch Pharmacol, 360: 510-521. [PMID:10598790]
47. Siehler S, Seuwen K, Hoyer D. (1998) [125I]Tyr10-cortistatin14 labels all five somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol, 357 (5): 483-9. [PMID:9650799]
48. Siehler S, Seuwen K, Hoyer D. (1999) Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies. Naunyn Schmiedebergs Arch Pharmacol, 360 (5): 488-99. [PMID:10598788]
49. Stroh T, Sarret P, Tannenbaum GS, Beaudet A. (2006) Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem Res, 31 (2): 247-57. [PMID:16518576]
50. Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H. (2005) Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J, 52 (5): 605-11. [PMID:16284440]
51. Tulipano G, Soldi D, Bagnasco M, Culler MD, Taylor JE, Cocchi D, Giustina A. (2002) Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology, 143: 1218-1224. [PMID:11897676]
52. Unger N, Ueberberg B, Schulz S, Saeger W, Mann K, Petersenn S. (2012) Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues. Exp Clin Endocrinol Diabetes, 120 (8): 482-9. [PMID:22976314]
53. Van Op den Bosch J, van Nassauw L, Lantermann K, van Marck E, Timmermans JP. (2007) Effect of intestinal inflammation on the cell-specific expression of somatostatin receptor subtypes in the murine ileum. Neurogastroenterol Motil, 19 (7): 596-606. [PMID:17593141]
54. Viollet C, Bodenant C, Prunotto C, Roosterman D, Schaefer J, Meyerhof W, Epelbaum J, Vaudry H, Leroux P. (1997) Differential expression of multiple somatostatin receptors in the rat cerebellum during development. J Neurochem, 68 (6): 2263-72. [PMID:9166718]
55. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA, 89 (1): 251-5. [PMID:1346068]
56. Yamada Y, Stoffel M, Espinosa 3rd R, Xiang KS, Seino M, Seino S, Le Beau MM, Bell GI. (1993) Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms. Genomics, 15 (2): 449-52. [PMID:8449518]
57. Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW et al.. (1998) Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA, 95 (18): 10836-41. [PMID:9724791]